The Source Blog
Recent Action in Healthcare Costs
SB 49 – Maryland
Introduced: 2019 Status: Enacted
Removing the Maryland Insurance Commissioner, or the Commissioner’s designee, from the membership of the Task Force to Study Cooperative Purchasing for Health Insurance; and removing the requirement that the Maryland Insurance Administration provide staff for …
SB 871 (see companion bill HB 1087) – Maryland
Introduced: 2019 Status: Inactive / Dead
Providing that the General Assembly finds that all State residents have a right to health care; providing it is the intent of the General Assembly to establish a comprehensive universal single-payer health care coverage program …
SB 803 – Maryland
Introduced: 2019 Status: Inactive / Dead
Requiring certain hospitals to provide each patient with written notice that includes certain information related to outpatient facility fees that are charged for services provided at the hospital; requiring the Health Education and Advocacy Unit …
SB 761 – Maryland
Introduced: 2019 Status: Inactive / Dead
Requiring a carrier to inform members and beneficiaries of the procedure to request a certain referral to certain noncontracting health care providers; requiring, under certain circumstances, certain insurers, nonprofit health service plans, and health maintenance …
SB 665 (see companion bill HB 721) – Maryland
Introduced: 2019 Status: Inactive / Dead
Clarifying that, for purposes of provisions of law concerning health insurance, a chamber of commerce may be considered an association; repealing certain provisions of law that apply certain provisions of law governing small group market …
SB 315 (see companion bill HB 315) – Maryland
Introduced: 2019 Status: Inactive / Dead
Defining a “direct primary care agreement” as a written contract in which a primary care provider agrees to provide certain primary care services to a patient for a certain fee and for a certain period …
SB 1045 (see companion bill 1423) – Maryland
Introduced: 2019 Status: Inactive / Dead
Altering the fiscal years, from 2016 through 2019 to 2020 through 2022, in which the remaining fund balance in the Maryland Health Insurance Plan Fund obtained from the federal Medicare program or the Medicaid program …
Next | See all Legislation Records
Introduced: 2019 Status: Enacted
Removing the Maryland Insurance Commissioner, or the Commissioner’s designee, from the membership of the Task Force to Study Cooperative Purchasing for Health Insurance; and removing the requirement that the Maryland Insurance Administration provide staff for …
SB 871 (see companion bill HB 1087) – Maryland
Introduced: 2019 Status: Inactive / Dead
Providing that the General Assembly finds that all State residents have a right to health care; providing it is the intent of the General Assembly to establish a comprehensive universal single-payer health care coverage program …
SB 803 – Maryland
Introduced: 2019 Status: Inactive / Dead
Requiring certain hospitals to provide each patient with written notice that includes certain information related to outpatient facility fees that are charged for services provided at the hospital; requiring the Health Education and Advocacy Unit …
SB 761 – Maryland
Introduced: 2019 Status: Inactive / Dead
Requiring a carrier to inform members and beneficiaries of the procedure to request a certain referral to certain noncontracting health care providers; requiring, under certain circumstances, certain insurers, nonprofit health service plans, and health maintenance …
SB 665 (see companion bill HB 721) – Maryland
Introduced: 2019 Status: Inactive / Dead
Clarifying that, for purposes of provisions of law concerning health insurance, a chamber of commerce may be considered an association; repealing certain provisions of law that apply certain provisions of law governing small group market …
SB 315 (see companion bill HB 315) – Maryland
Introduced: 2019 Status: Inactive / Dead
Defining a “direct primary care agreement” as a written contract in which a primary care provider agrees to provide certain primary care services to a patient for a certain fee and for a certain period …
SB 1045 (see companion bill 1423) – Maryland
Introduced: 2019 Status: Inactive / Dead
Altering the fiscal years, from 2016 through 2019 to 2020 through 2022, in which the remaining fund balance in the Maryland Health Insurance Plan Fund obtained from the federal Medicare program or the Medicaid program …
Next | See all Legislation Records
Minnesota v. Sanofi-Aventis U.S. LLC – Minnesota
District Court: District Court of New Jersey Status: Pending
Minnesota’s attorney general filed a suit accusing Sanofi, Eli Lilly, and Novo Nordisk, the three largest manufacturers of insulin, of price gouging. The lawsuit, filed in …
Association for Accessible Medicines v. Frosh – Maryland
District Court: District of Maryland Status: Decided
In a significant victory for the pharmaceutical industry, the 4th U.S. Circuit Court of Appeals found Maryland’s landmark 2017 law (HB 631), which punishes generic …
Negron v. Cigna and OptumRx – Connecticut
District Court: District of Connecticut Status: Pending
Cigna faces a class-action lawsuit alleging the insurance giant overcharged its members by more than 10 times the amount the insurer paid for certain prescription …
In Re UnitedHealth Group PBM Litigation – Minnesota
District Court: District of Minnesota Status: Decided
Plan members brought suit against UnitedHealth Group, Inc. under ERISA and RICO for Defendants’ conduct in administrating pharmacy benefits that allegedly caused Plaintiffs to overpay …
Mohr-Lercara v. Oxford Health Ins., Inc. – New York
District Court: Southern District of New York Status: Pending
A proposed class action was filed in New York federal court accusing Oxford Health Insurance of overcharging patients for prescription drugs. The complaint alleges that …
Alcon Labs., Inc. v. Cottrell – New Jersey
District Court: District of New Jersey Status: Decided
Consumers brought putative class action against manufacturers and distributors of prescription eye medication, alleging they packaged medication in such a way as to force consumers …
In re Express Scripts/Anthem ERISA Litigation – New York
District Court: Southern District of New York Status: Pending
The district court dismissed a proposed class action against Anthem Inc. and Express Scripts Inc. over drug pricing methods, holding that the companies can’t be …
Next | See all Litigation Records
District Court: District Court of New Jersey Status: Pending
Minnesota’s attorney general filed a suit accusing Sanofi, Eli Lilly, and Novo Nordisk, the three largest manufacturers of insulin, of price gouging. The lawsuit, filed in …
Association for Accessible Medicines v. Frosh – Maryland
District Court: District of Maryland Status: Decided
In a significant victory for the pharmaceutical industry, the 4th U.S. Circuit Court of Appeals found Maryland’s landmark 2017 law (HB 631), which punishes generic …
Negron v. Cigna and OptumRx – Connecticut
District Court: District of Connecticut Status: Pending
Cigna faces a class-action lawsuit alleging the insurance giant overcharged its members by more than 10 times the amount the insurer paid for certain prescription …
In Re UnitedHealth Group PBM Litigation – Minnesota
District Court: District of Minnesota Status: Decided
Plan members brought suit against UnitedHealth Group, Inc. under ERISA and RICO for Defendants’ conduct in administrating pharmacy benefits that allegedly caused Plaintiffs to overpay …
Mohr-Lercara v. Oxford Health Ins., Inc. – New York
District Court: Southern District of New York Status: Pending
A proposed class action was filed in New York federal court accusing Oxford Health Insurance of overcharging patients for prescription drugs. The complaint alleges that …
Alcon Labs., Inc. v. Cottrell – New Jersey
District Court: District of New Jersey Status: Decided
Consumers brought putative class action against manufacturers and distributors of prescription eye medication, alleging they packaged medication in such a way as to force consumers …
In re Express Scripts/Anthem ERISA Litigation – New York
District Court: Southern District of New York Status: Pending
The district court dismissed a proposed class action against Anthem Inc. and Express Scripts Inc. over drug pricing methods, holding that the companies can’t be …
Next | See all Litigation Records
News & Opinions
Articles & Reports
Annals of Internal Medicine November 12, 2019
JAMA Internal Medicine November 11, 2019
Health Affairs November 4, 2019
Kaiser Family Foundation November 4, 2019
JAMA Internal Medicine November 11, 2019
Health Affairs November 4, 2019
Kaiser Family Foundation November 4, 2019